Controlling trisulfide modification in recombinant monoclonal antibody produced in fed‐batch cell culture
- 3 April 2012
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 109 (10) , 2523-2532
Abstract
Molecular heterogeneity was detected in a recombinant monoclonal antibody (IgG1 mAb) due to the presence of a trisulfide linkage generated by the post‐translational insertion of a sulfur atom into disulfide bonds at the heavy–heavy and heavy–light junctions. This molecular heterogeneity had no observable effect on antibody function. Nevertheless, to minimize the heterogeneity of the IgG1 mAb from run‐to‐run, an understanding of the impact of cell culture process conditions on trisulfide versus disulfide linkage formation was desirable. To investigate variables that might impact trisulfide formation, cell culture parameters were varied in bench‐scale bioreactor studies. Trisulfide analysis of the samples from these runs revealed that the trisulfide content in the bond between heavy and light chains varied considerably from <1% to 39%. Optimizing the culture duration and feeding strategy resulted in more consistent trisulfide levels. Cysteine concentration in the feed medium had a direct correlation with the trisulfide level in the product. Systematic studies revealed that cysteine in the feed and the bioreactor media was contributing hydrogen sulfide which reacted with the IgG1 mAb in the supernatant leading to the insertion of sulfur atom and formation of a trisulfide bond. Cysteine feed strategies were developed to control the trisulfide modification in the recombinant monoclonal antibody. Biotechnol. Bioeng. 2012; 109: 2523–2532.Keywords
This publication has 46 references indexed in Scilit:
- Characterization and Comparison of Disulfide Linkages and Scrambling Patterns in Therapeutic Monoclonal Antibodies: Using LC-MS with Electron Transfer DissociationAnalytical Chemistry, 2011
- Cell culture processes for monoclonal antibody productionmAbs, 2010
- Control of misincorporation of serine for asparagine during antibody production using CHO cellsBiotechnology and Bioengineering, 2010
- Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipmentBiotechnology Progress, 2010
- Evidence for Trisulfide Bonds in a Recombinant Variant of a Human IgG2 Monoclonal AntibodyAnalytical Chemistry, 2009
- Applications of CE SDS gel in development of biopharmaceutical antibody‐based productsElectrophoresis, 2008
- Removal of Cysteinylation from an Unpaired Sulfhydryl in the Variable Region of a Recombinant Monoclonal IgG1 Antibody Improves Homogeneity, Stability, and Biological ActivityJournal of Pharmaceutical Sciences, 2008
- Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stressCurrent Opinion in Pharmacology, 2007
- Production of recombinant protein therapeutics in cultivated mammalian cellsNature Biotechnology, 2004
- Products of γ-Irradiation of Cysteine and Cystine1Journal of the American Chemical Society, 1960